Protein Disulfide Isomerase Human Recombinant ( PDI Human )

Catalog # PT_41876

Print

$327.00
DescriptionPDI Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 503 amino acids and having a molecular mass of 62.4 kDa. The PDI is fused to a 12 amino acid His tag (515 a.a. total) at N-terminal and
Product Size: 100ug
Quantity

Data sheet

Formulation
The PDI protein (1mg/ml)solution was lyophilized from PBS pH-7.
Solubility
It is recommended to reconstitute the lyophilized PDI in sterile 18M-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.
Purity
Greater than 95.0% as determined bya) Analysis by RP-HPLC.b) Analysis by SDS-PAGE.
Description
PDI Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 503 amino acids and having a molecular mass of 62.4 kDa. The PDI is fused to a 12 amino acid His tag (515 a.a. total) at N-terminal and purified by propr
Protein Background
Protein disulfide isomerases (PDIs) constitute a family of structurally related enzymes which catalyze disulfide bonds formation, reduction, or isomerization of newly synthesized proteins in the lumen of the endoplasmic reticulum (ER). They act also as ch
Expression host
Escherichia Coli.
Synonyms
Protein Disulfide Isomerase, PDI, EC 5.3.4.1, Prolyl 4-hydroxylase subunit beta, Cellular thyroid hormone-binding protein, p55, P4HB, ERBA2L, PDIA1, PO4DB, DSI, GIT, PHDB, PO4HB, PROHB, P4Hbeta.
Reagent Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Stability
Lyophilized Protein Disulfide Isomerase although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Human PDI should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage
Amino acid sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Arg-Arg-Ala.
References
Title: Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction Publications: Blood 113.8 (2009): 1681-1688. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647666/
New